JP2023515101A5 - - Google Patents
Info
- Publication number
- JP2023515101A5 JP2023515101A5 JP2022550119A JP2022550119A JP2023515101A5 JP 2023515101 A5 JP2023515101 A5 JP 2023515101A5 JP 2022550119 A JP2022550119 A JP 2022550119A JP 2022550119 A JP2022550119 A JP 2022550119A JP 2023515101 A5 JP2023515101 A5 JP 2023515101A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disorder
- alkyl
- present
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025078577A JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
| JP2026005770A JP2026067907A (ja) | 2020-02-21 | 2026-01-16 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980143P | 2020-02-21 | 2020-02-21 | |
| US62/980,143 | 2020-02-21 | ||
| PCT/US2021/019113 WO2021168446A1 (en) | 2020-02-21 | 2021-02-22 | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025078577A Division JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515101A JP2023515101A (ja) | 2023-04-12 |
| JP2023515101A5 true JP2023515101A5 (enExample) | 2024-09-18 |
Family
ID=77391353
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550119A Withdrawn JP2023515101A (ja) | 2020-02-21 | 2021-02-22 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
| JP2025078577A Active JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
| JP2026005770A Pending JP2026067907A (ja) | 2020-02-21 | 2026-01-16 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025078577A Active JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
| JP2026005770A Pending JP2026067907A (ja) | 2020-02-21 | 2026-01-16 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240018146A1 (enExample) |
| EP (1) | EP4106874A4 (enExample) |
| JP (3) | JP2023515101A (enExample) |
| KR (2) | KR20220158290A (enExample) |
| CN (1) | CN115515682B (enExample) |
| AU (1) | AU2021222053A1 (enExample) |
| BR (1) | BR112022016614A2 (enExample) |
| CA (1) | CA3168531A1 (enExample) |
| CO (1) | CO2022013603A2 (enExample) |
| CR (1) | CR20220476A (enExample) |
| EC (1) | ECSP22074210A (enExample) |
| IL (2) | IL326926A (enExample) |
| MX (2) | MX2022010309A (enExample) |
| PH (1) | PH12022552518A1 (enExample) |
| WO (1) | WO2021168446A1 (enExample) |
| ZA (1) | ZA202210409B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3947390A4 (en) * | 2019-04-03 | 2022-11-30 | Mitokinin, Inc. | COMPOSITIONS AND METHODS FOR THEIR USE FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE |
| CN119752781B (zh) * | 2025-03-04 | 2025-07-01 | 中国农业大学 | 缓解成熟卵子老化的组合物、培养液、产品及方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
| TW200508224A (en) * | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| HRP20120786T1 (hr) * | 2006-02-02 | 2012-11-30 | Millennium Pharmaceuticals, Inc. | Inhibitori aktivirajuä†eg enzima e1 |
| SG174772A1 (en) * | 2006-09-11 | 2011-10-28 | Curis Inc | Multi-functional small molecules as anti-proliferative agents |
| EP2342178B1 (en) * | 2008-09-02 | 2016-09-28 | Sanofi | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| AU2014214561C1 (en) * | 2013-02-11 | 2019-01-17 | Mitokinin, Inc. | Compositions and methods for treating neurodegenerative diseases |
| WO2018237145A1 (en) * | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
-
2021
- 2021-02-22 KR KR1020227032526A patent/KR20220158290A/ko active Pending
- 2021-02-22 US US17/801,450 patent/US20240018146A1/en active Pending
- 2021-02-22 CN CN202180025593.5A patent/CN115515682B/zh active Active
- 2021-02-22 WO PCT/US2021/019113 patent/WO2021168446A1/en not_active Ceased
- 2021-02-22 CR CR20220476A patent/CR20220476A/es unknown
- 2021-02-22 MX MX2022010309A patent/MX2022010309A/es unknown
- 2021-02-22 IL IL326926A patent/IL326926A/en unknown
- 2021-02-22 KR KR1020267019334A patent/KR20260098022A/ko active Pending
- 2021-02-22 BR BR112022016614A patent/BR112022016614A2/pt unknown
- 2021-02-22 EP EP21757063.9A patent/EP4106874A4/en active Pending
- 2021-02-22 JP JP2022550119A patent/JP2023515101A/ja not_active Withdrawn
- 2021-02-22 AU AU2021222053A patent/AU2021222053A1/en active Pending
- 2021-02-22 CA CA3168531A patent/CA3168531A1/en active Pending
- 2021-02-22 PH PH1/2022/552518A patent/PH12022552518A1/en unknown
-
2022
- 2022-08-16 IL IL295681A patent/IL295681B2/en unknown
- 2022-08-19 MX MX2026003961A patent/MX2026003961A/es unknown
- 2022-09-20 ZA ZA2022/10409A patent/ZA202210409B/en unknown
- 2022-09-21 EC ECSENADI202274210A patent/ECSP22074210A/es unknown
- 2022-09-21 CO CONC2022/0013603A patent/CO2022013603A2/es unknown
-
2025
- 2025-05-09 JP JP2025078577A patent/JP7808226B2/ja active Active
-
2026
- 2026-01-16 JP JP2026005770A patent/JP2026067907A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013355220B2 (en) | Functionalized benzamide derivatives as antiviral agents against HBV infection | |
| CA2257393C (en) | Compositions and methods for reducing respiratory depression | |
| ES2987512T3 (es) | Inhibidor de EZH2 combinado con un inhibidor de BTK para el tratamiento de tumores | |
| JP2022527025A5 (enExample) | ||
| JP5313881B2 (ja) | テトラヒドロイソキノリン化合物 | |
| EA002763B1 (ru) | Альфа-аминоамидные производные, полезные в качестве анальгетических агентов | |
| JP2013531006A (ja) | Ｋｖ７カリウムチャネル開口薬としてのピペリジニルピリミジンアミド | |
| KR20140097127A (ko) | 아닐린 유도체, 그의 제조법 및 그의 치료 용도 | |
| CN115916766A (zh) | 新型吡唑衍生物 | |
| JP2025511875A5 (enExample) | ||
| JP2012500247A (ja) | 末梢神経障害の治療のための化合物 | |
| JP2021527650A5 (enExample) | ||
| CN111518028A (zh) | 一种一氧化氮供体型ripasudil衍生物及其制备方法和用途 | |
| JP2008519783A5 (enExample) | ||
| JP2024509625A5 (enExample) | ||
| RU2008109821A (ru) | Способ и композиция для стимуляции нейрогенеза и ингибирования дегенерации нейронов | |
| KR101135911B1 (ko) | 축합 고리 화합물 및 그 용도 | |
| US20230312481A1 (en) | Substituted (phthalazin-1-ylmethyl)ureas, substituted n-(phthalazin-1-ylmethyl)amides, and analogues thereof | |
| TW200944194A (en) | Pharmaceutical composition for treatment of neurodegenerative disorders | |
| RU2008123395A (ru) | Новые n-сульфамоил-n-бензопиранпиперидины, предназначенные для применения в медицине | |
| CN121311470A (zh) | 吡啶和二氢吡啶化合物及其用途 | |
| CN120923428A (zh) | 流感病毒核酸内切酶抑制剂及其应用 | |
| CN1845911B (zh) | 稠环化合物及其应用 | |
| WO2023174314A9 (zh) | 氮杂环丁烷衍生物的用途及治疗方法 | |
| EP0434093A1 (en) | Omega-amino-alpha-phenylalkano-nitrile derivatives |